Next Article in Journal
The Efficacy, the Treatment Response and the Aquaretic Effects of a Three-Year Tolvaptan Regimen in Polycystic Kidney Disease Patients
Previous Article in Journal
Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience
 
 
Case Report

Article Versions Notes

Clin. Pract. 2023, 13(5), 1025-1034; https://doi.org/10.3390/clinpract13050091
Action Date Notes Link
article xml file uploaded 24 August 2023 07:34 CEST Original file -
article xml uploaded. 24 August 2023 07:34 CEST Update https://www.mdpi.com/2039-7283/13/5/91/xml
article pdf uploaded. 24 August 2023 07:34 CEST Version of Record https://www.mdpi.com/2039-7283/13/5/91/pdf
article html file updated 24 August 2023 07:36 CEST Original file https://www.mdpi.com/2039-7283/13/5/91/html
Back to TopTop